Abstract
American trypanosomiasis (Chagas disease) is a neglected disease with about 12 million people chronically infected and more than 40 million at risk of infection. Nowadays the few drugs available to treat the disease are limited in efficacy and tolerance, which highlights the need for new therapeutic targets to development of effective drugs for treatment. Studies have described the import…